Navigation Links
Perfusion bioreactor could enhance stem cell research and application in the future

Florida State University researchers have now developed a new medical device that is believed to allow bone marrow derived stem cells to be grown in sufficient quantities to permit far more research and allow faster growth of// tissues. This overcomes the currently involved technical difficulties in the growth and transplantation of stem cells. The device called a perfusion bioreactor is designed to mimic conditions encountered by adult stem cells within the human body. The protein rich fluid produced by the reactor bathes the stem cell samples to provide nourishment by a parallel simulation of circulatory system. The perfusion bioreactor allows the delivery of essential nutrients in a physiological way. Furthermore, the researchers hope to alter the fate of each stem cell by altering the nutrient flow. If this is appropriately designed, the stem cell can give rise to a blood cell, nerve cell or a skin cell depending on the need. The stem cells derived from mesenchymal cells and processed in the bioreactor are viable for a period of 40 days and can be directed to differentiate into bone, cartilage, muscle, heart muscle, fat or nerve tissue. The stem cells produced in this way are ideally suitable for clinical transplantation. The current development overcomes the need of using fetal or embryonic tissue and eliminates the ethical concerns associated with the same as the mesenchymal stem cells can be extracted from adult donors. The stem cells for the present study were extracted through a medical procedure in which a small amount of bone marrow is extracted from the donors’ pelvic bone. Within that extracted bone marrow, only about one in every 100,000 cells is a stem cell. The rarity of finding bone marrow derived adult stem cell and technical difficulties involved in growth and multiplication of the stem cells posed a significant challenge to the researchers. However, the research team successfully overcame these shortcomings to achieve the desired resul ts. The present study may eventually pave way for significant breakthroughs in the field of stem cell research and application and help advance the development of numerous medical therapies in the years to come.
'"/>




Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Beware of the oral patch! It could be cancer!!!
3. Prozac miracle could end in disaster
4. Wonder drug - could end in disaster
5. Pollution could be a risk
6. Fright could be more harmful
7. Pregnant smokers could harm their child
8. Snoring could be a warning
9. Anthrax drug doxycycline could stunt fetal growth
10. Hike in drug licence fee could hit several SSI units in TN
11. Lengthy Fingers could predict heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: